Speakers

Your 2024 speaker faculty:

Fabien GarconGlanville

Fabien Garcon
Senior Scientist

AstraZeneca

Hongyan Sun

Hongyan Sun
Senior Scientist 

GemPharmatech

Ilona-Petra Maser

Ilona-Petra Maser
Senior Scientist & Group Leader

iOmx Therapeutics

Joel Plumas

Joel Plumas
Co-Founder & Chief Scientific Officer

PDC*line Pharma

Loïc Poiraudeau

Loic Poiraudeau
Postdoctoral Fellow

Institute Gustave Roussy

Lucas Chaible

Lucas Chaible
Senior Scientist

iTeos Therapeutics

Lucas Trucco

Lucas Trucco
Principal Scientist, Oncology

Johnson & Johnson Innovative Medicine

Madelon Paauwe

Madelon Paauwe
Senior Scientist - Preclinical In Vivo Pharmacology

Genmab

Mads Daugaard

Mads Daugaard
President & Chief Scientific Officer

Rakovina Therapeutics

Mark Albertella

Mark Albertella
Senior Director – Oncology Biosciences

AstraZeneca

Martyna Popis

Martyna Popis
Scientist, Cell & Antibody Therapy

MiNK Therapeutics

Michaela Nahler

Michaela Nahler
Head of Regulatory Affairs, Former Senior Director, Head Regulatory Affairs Europe

Urovant Sciences

Nicholas Glanville

Nicholas Glanville
Vice President Research

Prokarium

Paola Marco-Casanova

Paola Marco-Casanova
Director, Translational Medicine, Oncology R&D

AstraZeneca

Philip Huxley

Philip Huxley
Vice President – Oncology

Bicycle Therapeutics

Ravashnee Naidoo

Ravashnee Naidoo
Senior Scientist –Tumour Profiling, Translational Sciences Group

Adaptimmune Therapeutics

Servier

Shamin Li
In Vitro Pharmacology Team Leader

Servier

Somaieh Hedayat

Somaieh Hedayat
Principal Scientist, Translational Models Lead

Econic Biosciences

Stefan Bissinger

Stefan Bissinger
Head of Preclinical Pharmacology & Biomarker Development

iOmx Therapeutics